Brandon Capital
Venture-Capital-and-Private-Equity-Principals
Website
Company Tagline
Transforming the most promising medical discoveries into life-changing commercial products that improve patients' lives
Industry Category
Business Keywords
Company Description
Brandon Capital is a leading venture capital and private equity firm dedicated to transforming groundbreaking medical discoveries into life-changing commercial products. With a robust global network spanning the US and UK, Brandon Capital fosters collaboration and strategic investment to propel the most promising medical research breakthroughs forward. The firm is committed to supporting life science companies from initial proof-of-concept through to full-scale commercialization.
Located at 31 Queen St, Level 9, Melbourne, Victoria 3000, AU, Brandon Capital actively supports the biomedical industry, providing crucial expansion capital and early-stage seed investment. Brandon Capital's dedication extends to its other locations, including 56 Pitt Street, Suite 3.02, Sydney, New South Wales 2000, AU; 1 Letterman Dr, Suite C3-300, San Francisco, California 94129, US; and 7 Pancras Square, King's Cross, England N1C 4AG, GB, ensuring comprehensive support for its portfolio companies.
Brandon Capital's mission is to drive innovation and improve patient outcomes through strategic investments and partnerships. Brandon Capital invites you to explore how it can assist your company in achieving its commercial objectives. We encourage the manager of Brandon Capital to create a customized and exclusive company showcase and product listing on our platform to further enhance its visibility and market presence.
Brandon Capital est une société de capital-risque et de capital-investissement de premier plan, dédiée à la transformation de découvertes médicales révolutionnaires en produits commerciaux qui changent des vies. Fort d'un solide réseau mondial couvrant les États-Unis et le Royaume-Uni, Brandon Capital favorise la collaboration et les investissements stratégiques pour faire progresser les découvertes de recherche médicale les plus prometteuses. L'entreprise s'engage à soutenir les sociétés de sciences de la vie, de la preuve de concept initiale à la commercialisation à grande échelle.
Située au 31 Queen St, Level 9, Melbourne, Victoria 3000, AU, Brandon Capital soutient activement l'industrie biomédicale, en fournissant des capitaux d'expansion essentiels et des investissements de démarrage précoces. Le dévouement de Brandon Capital s'étend à ses autres sites, notamment 56 Pitt Street, Suite 3.02, Sydney, New South Wales 2000, AU ; 1 Letterman Dr, Suite C3-300, San Francisco, California 94129, US ; et 7 Pancras Square, King's Cross, England N1C 4AG, GB, assurant un soutien complet à ses sociétés en portefeuille.
La mission de Brandon Capital est de stimuler l'innovation et d'améliorer les résultats pour les patients grâce à des investissements et des partenariats stratégiques. Brandon Capital vous invite à découvrir comment elle peut aider votre entreprise à atteindre ses objectifs commerciaux. Nous encourageons le directeur de Brandon Capital à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer encore sa visibilité et sa présence sur le marché.
Key Personnel / Employees
Compare Companies Side by Side
Compare Brandon Capital with 3 companies in Venture-Capital-and-Private-Equity-Principals
| Comparison Field |
Brandon CapitalMain Company |
Deep Knowledge GroupView Profile |
CellBiOasisView Profile |
H7 BioCapitalView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2014 | 2008 | |
|
Company Size
|
— | 51-200 | 11-50 | 11-50 |
|
City
|
Melbourne, Victoria | London, England | Pune, Maharashtra | San Francisco , California |
|
Country
|
Australia | United Kingdom | India | |
|
Skills & Keywords
Comparing with main company
|
15 Total Skills
Venture Capital
Private Equity
Life Science Investment
Biomedical Commercialization
Early-Stage Investing
Expansion Capital
Medical Research
early-stage investing
commercialisation
venture capital
expansion capital
life science
biomedical commercialisation
biotechnology
seed investing
|
17 Total
17 Unique
Unique Skills:
aging
AI
artificial intelligence
big data analysis
biomedicine
bioscience
+11
|
3 Total
3 Unique
Unique Skills:
Lab Services
Laboratory Supply Chain Programs & eCommerce
Pharma Services
|
22 Total
22 Unique
Unique Skills:
accelerator
advisors
artificial intelligence
biotech
commercialization
community
+16
|
4
Total Companies2008
Oldest Founded3
Countries56
Unique SkillsSimilar Companies
Other organizations in the same industry
SIMRO Invest
Venture-Capital-and-Private-Equity-PrincipalsMaking impact together
ICI Fund
Venture-Capital-and-Private-Equity-PrincipalsInnovation. Community. Intelligence. US VC firm investing in Israeli founders with AI solutions secu...
London Venture Capital
Venture-Capital-and-Private-Equity-PrincipalsLondon Venture Capital is a monthly networking event connecting VCs founders & advisors across the s...
Alternative Company Names
This company is also known as